Jay Ariyawansa

462 total citations
22 papers, 361 citations indexed

About

Jay Ariyawansa is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Anesthesiology and Pain Medicine. According to data from OpenAlex, Jay Ariyawansa has authored 22 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Anesthesiology and Pain Medicine. Recurrent topics in Jay Ariyawansa's work include Atrial Fibrillation Management and Outcomes (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Pain Management and Opioid Use (2 papers). Jay Ariyawansa is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Pain Management and Opioid Use (2 papers). Jay Ariyawansa collaborates with scholars based in United States, Belgium and Germany. Jay Ariyawansa's co-authors include Kenneth Todd Moore, Joe Murphy, William B. Smith, Clapton Dias, Roger M. Mills, Nicole Vaccaro, Jaya Natarajan, K. C. Turner, Alexei N. Plotnikov and Paul Burton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Pharmacokinetics and Journal of Thrombosis and Haemostasis.

In The Last Decade

Jay Ariyawansa

21 papers receiving 349 citations

Peers

Countries citing papers authored by Jay Ariyawansa

Since Specialization

Citations

This map shows the geographic impact of Jay Ariyawansa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Ariyawansa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Ariyawansa more than expected).

Fields of papers citing papers by Jay Ariyawansa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Ariyawansa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Ariyawansa. The network helps show where Jay Ariyawansa may publish in the future.

Co-authorship network of co-authors of Jay Ariyawansa

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Ariyawansa. A scholar is included among the top collaborators of Jay Ariyawansa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Ariyawansa. Jay Ariyawansa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Randomized Trial on the Combined Effect of Ponesimod and Propranolol on Heart Rate, Cardiac Safety, and Pharmacokinetics in Healthy Adults 2025 ·Clinical and Translational Science ·Sivi Ouwerkerk‐Mahadevan, (unknown), Italo Poggesi, Eva Vets, Freya Rasschaert, Jay Ariyawansa, Jaya Natarajan, (unknown), Andrea Vaclavkova, Juan José Pérez Ruixo, (unknown)	1
2	Evaluation of the Effect of Loperamide on the Cardiac Repolarization Interval Using Exposure–Response Analysis 2025 ·Clinical and Translational Science ·Belén Valenzuela, Per Olsson, (unknown), (unknown), Jay Ariyawansa, (unknown), (unknown), Juan José Pérez Ruixo, (unknown)	0
3	Pharmacokinetic interaction between single and multiple doses of darunavir, in combination with cobicistat or ritonavir, and single-dose dabigatran etexilate in healthy adults 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Jay Ariyawansa, (unknown), (unknown), (unknown)	1
4	Effect of loperamide on heart rhythm: Randomized, double-blind, controlled study in healthy adults 2024 ·(unknown), Jay Ariyawansa, (unknown), Evren Atillasoy	1
5	Bioequivalence of a Pediatric Fixed‐Dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Compared With Coadministration of the Separate Agents in Healthy Adults: An Open‐Label, Randomized, Replicate Crossover Study 2023 ·Clinical Pharmacology in Drug Development ·(unknown), (unknown), Jay Ariyawansa, Simon Vanveggel, (unknown)	2
6	Comparison of a transdermal contraceptive patch with a newly sourced adhesive component versus EVRA patch: A double-blind, randomized, bioequivalence and adhesion study in healthy women 2020 ·Contraception ·Dolly A. Parasrampuria, (unknown), Jay Ariyawansa, (unknown), Jaya Natarajan, Freya Rasschaert, Joseph Massarella, (unknown)	6
7	<p>First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18</p> 2019 ·Journal of Pain Research ·Julia C. Finkel, (unknown), Ronald Rosenburg, Jay Ariyawansa, Tao Sun, Rachel Ochs-Ross, Peter Zannikos, (unknown), Mila Etropolski	14
8	Bioequivalence and safety of a novel fentanyl transdermal matrix system compared with a transdermal reservoir system 2018 ·Journal of Opioid Management ·Kenneth Todd Moore, (unknown), Jaya Natarajan, Jay Ariyawansa, (unknown)	2
9	Tramadol Hydrochloride at Steady State Lacks Clinically Relevant QTc Interval Increases in Healthy Adults 2018 ·Clinical Pharmacology in Drug Development ·Joseph Massarella, Jay Ariyawansa, Jaya Natarajan, Stephan Francke, (unknown), (unknown), (unknown), (unknown)	11
10	Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers 2017 ·Journal of Thrombosis and Haemostasis ·Jerrold H. Levy, Kenneth Todd Moore, Matthew D. Neal, David J. Schneider, (unknown), Jay Ariyawansa, Jeffrey I. Weitz	39
11	Safety, Tolerability, and Pharmacokinetics of Therapeutic and Supratherapeutic Doses of Tramadol Hydrochloride in Healthy Adults: A Randomized, Double‐Blind, Placebo‐Controlled Multiple‐Ascending‐Dose Study 2017 ·Clinical Pharmacology in Drug Development ·(unknown), (unknown), Joris Vandenbossche, Jay Ariyawansa, Jaya Natarajan, (unknown), (unknown), (unknown), Henning Stahlberg	6
12	Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis 2016 ·American Journal of Nephrology ·Clapton Dias, Kenneth Todd Moore, Joe Murphy, Jay Ariyawansa, William B. Smith, Roger M. Mills, (unknown)	93
13	Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole 2016 ·Clinical Pharmacology in Drug Development ·Bart Remmerie, Marc De Meulder, Jay Ariyawansa, Adam Savitz	6
14	Pharmacokinetics and Safety of Single Intravenous Doses of JNJ-54452840, an Anti-β1-Adrenergic Receptor Antibody Cyclopeptide, in Healthy Male Japanese and Caucasian Participants 2015 ·Clinical Pharmacokinetics ·Ivo Nnane, (unknown), Gary Peters, (unknown), (unknown), (unknown), Jay Ariyawansa, Ronald P. de Vries, Brian E. Davies	5
15	Drug‐Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended‐Release Tablets in Healthy Participants and Patients with Psychiatric Disorders 2015 ·The Journal of Clinical Pharmacology ·Bart Remmerie, Jay Ariyawansa, Marc De Meulder, Danielle Coppola, Joris Berwaerts	15
16	Effect of food on the pharmacokinetics of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, and assessment of dose proportionality in healthy participants 2014 ·Clinical Pharmacology in Drug Development ·Damayanthi Devineni, Prasarn Manitpisitkul, Joseph Murphy, Hans Stieltjes, Jay Ariyawansa, Nicholas A. Di Prospero, Paul Rothenberg	11
17	An open‐label study to estimate the effect of steady‐state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function 2014 ·The Journal of Clinical Pharmacology ·Kenneth Todd Moore, (unknown), Jaya Natarajan, Jay Ariyawansa, Lloyd Haskell, K. C. Turner	42
18	Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Rivaroxaban 2011 ·Journal of Cardiovascular Pharmacology ·Kenneth Todd Moore, Alexei N. Plotnikov, (unknown), Nicole Vaccaro, Jay Ariyawansa, Paul Burton	47
19	Effect of Carisbamate on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Participants 2011 ·The Journal of Clinical Pharmacology ·Martha Gonzalez, Peter Zannikos, Allitia DiBernardo, H. Robert Brashear, Jay Ariyawansa	1
20	A Randomized Study of the Effects of Food on the Pharmacokinetics of Once-Daily Extended-Release Hydromorphone in Healthy Volunteers 2010 ·The Journal of Clinical Pharmacology ·Kenneth Todd Moore, (unknown), (unknown), Jay Ariyawansa, Véronique Pagé, (unknown), (unknown), Ute Richarz	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact